Salmonella enterica serovar Dublin, which can cause enteritis and systemic infections in humans, has been associated with antimicrobial resistance. Here, we report draft genome sequences of seven multidrug-resistant S. Dublin isolates from human samples. These sequences will contribute to an understanding of pathogenesis and resistance determinants in this serovar.
ABSTRACT
Salmonella enterica serovar Dublin, which can cause enteritis and systemic infections in humans, has been associated with antimicrobial resistance. Here, we report draft genome sequences of seven multidrug-resistant S. Dublin isolates from human samples. These sequences will contribute to an understanding of pathogenesis and resistance determinants in this serovar.
ANNOUNCEMENT
Salmonella enterica serovar Dublin, a significant cause of foodborne diseases for animals and humans, is generally transmitted through unpasteurized milk and cheese (1, 2). It is also known to have a propensity for causing invasive infections with multidrug resistance, which complicates the therapeutic approach (1, 3–6). In this report, we present seven draft genome sequences of S. Dublin isolates collected from humans in Nebraska.
Blood, MacConkey, chocolate, and/or Hektoen enteric agar plates were used to culture human stool, blood, and synovial fluid specimens. Bacterial cultures were incubated overnight at 35°C. Salmonella species are non-lactose fermenters and H2S producers. A MicroScan WalkAway system (Beckman Coulter, Brea, CA) was used for identification of Salmonella species (Table 1). Serovar designations were made by pulsed-field gel electrophoresis and subsequently confirmed by whole-genome sequencing (WGS) using the MiSeq platform (Illumina, CA, USA). Strains from overnight cultures were tested for antimicrobial susceptibility to certain antibiotics using the disk diffusion method and interpreted using CLSI guidelines (Table 1).
TABLE 1.
Summary characteristics of whole-genome sequencing of multidrug-resistant Salmonella serovar Dublin strainsa
| Strain | No. of contigs | Genome size (bp) | N50 | GC content (%) | No. of genes | RNA genes | AMR phenotypeb | Resistance genesc | GenBank accession no. | SRA accession no.d |
|---|---|---|---|---|---|---|---|---|---|---|
| SD_190068 | 92 | 4,923,539 | 405,624 | 52.11 | 4,989 | 114 | AM, CAZ, TE, C | blaCMY-2, blaTEM-1B, floR, strA, strB, sul2, tetA | VACG00000000 | SRR9641963 |
| SD_180610 | 45 | 4,978,985 | 478,715 | 52.11 | 5,016 | 112 | AM, CAZ, TE, C | blaCMY-2, blaTEM-1B, floR, strA, strB, sul2, tetA | VDCP00000000 | SRR9641967 |
| SD_180280e | 50 | 4,979,905 | 494,424 | 52.11 | 5,032 | 115 | AM, CAZ, TE, C, CIP | blaCMY-2, blaTEM-1B, floR, strA, strB, sul2, tetA, gyrA D87N | VACH00000000 | SRR9641964 |
| SD_170735e | 65 | 5,136,349 | 402,292 | 52.11 | 5,179 | 121 | AM, CAZ, TE, C, CIP | blaCMY-2, blaTEM-1B, floR, strA, strB, sul2, tetA, gyrA D87G | VACM00000000 | SRR9641961 |
| SD_170156 | 73 | 4,962,240 | 420,579 | 52.09 | 5,035 | 116 | AM, CAZ, TE, C | blaCMY-2, floR, strA, strB, sul2, tetA | VACN00000000 | SRR9641962 |
| SD_12500 | 51 | 4,984,528 | 478,716 | 52.1 | 5,032 | 117 | AM, CAZ, TE, C, SXT | blaCMY2, blaTEM-1B, floR, strA, tetA, strB, sul2 | VACK00000000 | SRR9641959 |
| SD_7855 | 75 | 5,095,495 | 204,878 | 51.89 | 5,171 | 117 | AM, TE, C | blaTEM-1A, catA1, strA, strB, sul1, tetB, aadA1, aph(3′)-Ic | VACJ00000000 | SRR9641966 |
Sequence type by MLST for all strains was sequence type 10 (ST10).
Testing performed by the disc diffusion method. AMR, antimicrobial resistance; AM, ampicillin; CAZ, ceftazidime; TE, tetracycline; C, chloramphenicol; CIP, ciprofloxacin; SXT, trimethoprim-sulfamethoxazole.
β-Lactam resistance genes, blaCMY-2, blaTEM-1B; chloramphenicol resistance genes, floR and catA1; fluoroquinolone resistance genes, gyrA mutations; aminoglycoside resistance genes, strA, strB, aadA1, and aph(3′)-Ic; tetracycline resistance genes, tetA and tetB; sulfonamide resistance genes, sul1 and sul2.
SRA, Sequence Read Archive.
These two strains showed intermediate susceptibility to ciprofloxacin due to gyrA mutations.
A single colony of an overnight blood agar plate culture at 35°C was used for genomic DNA extraction using the MagNA Pure compact nucleic acid isolation kit I using the MagNA Pure compact instrument (Roche Diagnostics, IN, USA). DNA quality and quantity were determined using the NanoDrop 2000 UV-visible spectrophotometer (Fisher, MA, USA) and the Qubit 3.0 fluorometer (Invitrogen, CA, USA), respectively.
Genomic libraries were prepared using the Nextera XT library prep kit (Illumina) as instructed by the manufacturer. WGS was performed according to the manufacturer’s protocol using a 250-bp paired-end chemistry. The following parameters were used to assess the quality of the run: Phred quality score (quality score 30 > 75%), cluster density (600 to 1,300), and percentage of clusters passing filters (>80%). Default parameters were used for all bioinformatics software unless otherwise specified. The quality of the sequence reads was evaluated using FastQC 0.10. After subsequent quality trimming using Trimmomatic 0.33, the contigs of genomic sequences were de novo assembled using SPAdes 3.12, and contigs with a size less than 200 bp were filtered out using BBmap 38.06. The quality of the de novo assembled genomes were determined using QUAST 4.1 (Table 1). The draft genome of each strain was annotated using the NCBI Prokaryotic Genome Annotation Pipeline (PGAP) 4.8 (https://www.ncbi.nlm.nih.gov/genome/annotation_prok/). All bioinformatics tools used in this study except PGAP were made available through https://github.com/github.
The multilocus sequence types (MLST) were determined using MLST 2.0 as previously described (7). ResFinder 3.1 was used to identify antimicrobial resistance determinants, including acquired resistance genes and/or chromosomal mutations (8).
The average genome size of the sequenced isolates was 5,008,720 bp (range, 4,859,717 to 5,136,349 bp), the average number of contigs was 64 (range, 45 to 92), and the average N50 value was 412,175 (range, 204,878 to 494,424) (Table 1).
The collected data provides a basis for comparison with other S. Dublin strains and studies for epidemiology, surveillance, antimicrobial resistance, and pathogenesis.
Data availability.
The BioProject number for these sequences is PRJNA541980. GenBank accession numbers, Sequence Read Archive (SRA) accession numbers, numbers of contigs, N50 values, numbers of RNA genes, MLSTs, susceptibilities, and genotypic resistance profiles are provided in Table 1.
ACKNOWLEDGMENTS
This work was completed utilizing the Holland Computing Center at the University of Nebraska—Lincoln, which receives support from the Nebraska Research Initiative.
We thank the CDC for supporting this study through grant CK14-140105PPHF18.
REFERENCES
- 1.Harvey RR, Friedman CR, Crim SM, Judd M, Barrett KA, Tolar B, Folster JP, Griffin PM, Brown AC. 2017. Epidemiology of Salmonella enterica serotype Dublin infections among humans, United States, 1968–2013. Emerg Infect Dis 23:1493–1501. doi: 10.3201/eid2309.170136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Majowicz SE, Musto J, Scallan E, Angulo FJ, Kirk M, O’Brien SJ, Jones TF, Fazil A, Hoekstra RM, International Collaboration on Enteric Disease “Burden of Illness” Studies . 2010. The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis 50:882–889. doi: 10.1086/650733. [DOI] [PubMed] [Google Scholar]
- 3.Mohammed M, Vignaud ML, Cadel-Six S. 2019. Whole-genome sequences of two Salmonella enterica serovar Dublin strains that harbor the viaA, viaB, and ompB loci of the Vi antigen. Microbiol Resour Announc 8:e00028-19. doi: 10.1128/MRA.00028-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Harhay DM, Smith TPL, Harhay GP, Loneragan GH, Webb HE, Bugarel M, Haley BJ, Kim SW, Van Kessel J. 2018. Complete closed genome sequences of three Salmonella enterica subsp. enterica serovar Dublin strains isolated from cattle at harvest. Microbiol Resour Announc 7:e01334-18. doi: 10.1128/MRA.01334-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Carroll LM, Wiedmann M, den Bakker H, Siler J, Warchocki S, Kent D, Lyalina S, Davis M, Sischo W, Besser T, Warnick LD, Pereira RV. 2017. Whole-genome sequencing of drug-resistant Salmonella enterica isolates from dairy cattle and humans in New York and Washington states reveals source and geographic associations. Appl Environ Microbiol 83:e00140-17. doi: 10.1128/AEM.00140-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Cummings KJ, Virkler PD, Wagner B, Lussier EA, Thompson BS. 2018. Herd-level prevalence of Salmonella Dublin among New York dairy farms based on antibody testing of bulk tank milk. Zoonoses Public Health 65:1003–1007. doi: 10.1111/zph.12523. [DOI] [PubMed] [Google Scholar]
- 7.Larsen MV, Cosentino S, Rasmussen S, Friis C, Hasman H, Marvig RL, Jelsbak L, Sicheritz-Ponten T, Ussery DW, Aarestrup FM, Lund O. 2012. Multilocus sequence typing of total-genome-sequenced bacteria. J Clin Microbiol 50:1355–1361. doi: 10.1128/JCM.06094-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, Aarestrup FM, Larsen MV. 2012. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 67:2640–2644. doi: 10.1093/jac/dks261. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The BioProject number for these sequences is PRJNA541980. GenBank accession numbers, Sequence Read Archive (SRA) accession numbers, numbers of contigs, N50 values, numbers of RNA genes, MLSTs, susceptibilities, and genotypic resistance profiles are provided in Table 1.
